A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/505 (2006.01) A23L 1/303 (2006.01) A61K 31/68 (1990.01)
Patent
CA 2105881
ABSTRACT Treatment or prophylaxis of depressed or inadequate intracellular pyridoxal phosphate levels in a human or animal patient resulting from a condition, wherein the pyridoxine (PN) - pyridoxal phosphate (PLP) pathway is disturbed by cellulardefects and concomitant enzyme deficiences. These may be due to genetic causes or cell immaturity, as occurs in infants and in diseases resulting in erythrocytes destruction. In infants it was found, for the first time, that this leads to elevated homocysteine levels. The deficiencies are counteracted by the administration of pyridoxal or a precursor of pyridoxal which in vivo, once it has entered the bloodstream, is rapidly converted into pyridoxal without the intervention of oxidase or oxygen, optionally and preferably without the intervention of kinase and/or of PN in slow-release form and at a daily dosage rate not exceeding 0.7 mg/kg/day in the long term. In the case of pharmaceutical or dietary preparations for infants, in particular premature infants, these contain in addition vitamin B12 and folic acid or folate.
Borden Ladner Gervais Llp
Vesta Medicines (pty) Ltd.
LandOfFree
Compositions for the treatment and prophylaxis of metabolic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the treatment and prophylaxis of metabolic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the treatment and prophylaxis of metabolic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1358264